Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer’s disease: a prospective, observational study of factors affecting survival time from admission to death

BACKGROUND: The survival time in nursing homes (NHs) in Alzheimer’s disease (AD) might be affected by sociodemographic/clinical characteristics, rate of disease progression, and use of specific medications and community-based services. Whether different aspects of cholinesterase inhibitor (ChEI) the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wattmo, Carina, Londos, Elisabet, Minthon, Lennart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007849/
https://www.ncbi.nlm.nih.gov/pubmed/27581368
http://dx.doi.org/10.1186/s12883-016-0675-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007849/
https://www.ncbi.nlm.nih.gov/pubmed/27581368
http://dx.doi.org/10.1186/s12883-016-0675-3

Ejemplares similares